Mechanisms underlying prelimbic prefrontal cortex mGlu


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
01 2019
Historique:
received: 23 07 2018
revised: 22 09 2018
accepted: 12 10 2018
pubmed: 17 10 2018
medline: 5 3 2019
entrez: 17 10 2018
Statut: ppublish

Résumé

Stress can precipitate or worsen symptoms of many psychiatric illnesses. Dysregulation of the prefrontal cortex (PFC) glutamate system may underlie these disruptions and restoring PFC glutamate signaling has emerged as a promising avenue for the treatment of stress disorders. Recently, we demonstrated that activation of metabotropic glutamate receptor subtype 3 (mGlu

Identifiants

pubmed: 30326237
pii: S0028-3908(18)30406-4
doi: 10.1016/j.neuropharm.2018.10.013
pmc: PMC6286225
mid: NIHMS1510142
pii:
doi:

Substances chimiques

Central Nervous System Agents 0
Receptor, Metabotropic Glutamate 5 0
Receptors, Metabotropic Glutamate 0
metabotropic glutamate receptor 3 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-28

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH062646
Pays : United States
Organisme : NIMH NIH HHS
ID : K01 MH112983
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD083211
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH093366
Pays : United States
Organisme : NINDS NIH HHS
ID : R37 NS031373
Pays : United States

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Auteurs

Max E Joffe (ME)

Department of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA; Vanderbilt Center for Neuroscience Drug Discovery, Nashville, TN, 37232, USA; Vanderbilt Center for Addiction Research, Nashville, TN, 37232, USA. Electronic address: max.joffe@vanderbilt.edu.

Chiaki I Santiago (CI)

Vanderbilt Center for Neuroscience Drug Discovery, Nashville, TN, 37232, USA.

Branden J Stansley (BJ)

Department of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA; Vanderbilt Center for Neuroscience Drug Discovery, Nashville, TN, 37232, USA.

James Maksymetz (J)

Department of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA; Vanderbilt Center for Neuroscience Drug Discovery, Nashville, TN, 37232, USA.

Rocco G Gogliotti (RG)

Department of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA; Vanderbilt Center for Neuroscience Drug Discovery, Nashville, TN, 37232, USA.

Julie L Engers (JL)

Vanderbilt Center for Neuroscience Drug Discovery, Nashville, TN, 37232, USA.

Ferdinando Nicoletti (F)

Department of Physiology and Pharmacology, University Sapienza of Roma, 00185, Roma, Italy; IRCCS Neuromed, Pozzilli, Italy.

Craig W Lindsley (CW)

Department of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA; Vanderbilt Center for Neuroscience Drug Discovery, Nashville, TN, 37232, USA; Vanderbilt Center for Addiction Research, Nashville, TN, 37232, USA; Department of Chemistry, Vanderbilt University, Nashville, TN, 37232, USA.

P Jeffrey Conn (PJ)

Department of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA; Vanderbilt Center for Neuroscience Drug Discovery, Nashville, TN, 37232, USA; Vanderbilt Center for Addiction Research, Nashville, TN, 37232, USA. Electronic address: jeff.conn@vanderbilt.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH